Letters to the Editor
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
ATYPICAL DIFFERENTIATION SYNDROME WITH SUDDEN VISION LOSS IN ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA PLUS ATO: A CLINICAL CASE
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: June 29, 2024
850
Views
793
Downloads
80
HTML
Authors
Downloads
Download data is not yet available.
Citations
Gasparovic L, Weiler S, Higi L, Burden AM. Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature. J Clin Med. 2020;9(10). doi:10.3390/jcm9103342
Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157-162. doi:10.1111/bjh.16151
Rego EM, De Santis GC. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment. Mediterr J Hematol Infect Dis. 2011;3(1):e2011048. doi:10.4084/MJHID.2011.048
Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia. N Engl J Med. 2013;369(2):111-121. doi:10.1056/NEJMoa1300874
Sanz MA, Lo Coco F, Martín G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96(4):1247-1253.
Sanz MA, Montesinos P. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia. Blood. 2014;123(18):2777-2782. doi:10.1182/blood-2013-10-512640
Luesink M, Pennings JLA, Wissink WM, et al. Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009;114(27):5512-5521. doi:10.1182/blood-2009-02-204834
Newman AR, Leung B, Richards A, Campbell TG, Wellwood J, Imrie FR. Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide. Am J Ophthalmol Case Rep. 2018;9:106-111. doi:10.1016/j.ajoc.2018.01.026
Levasseur SD, Tantiworawik A, Lambert Maberley DA. All-trans retinoic Acid differentiation syndrome chorioretinopathy: a case of multifocal serous neurosensory detachments in a patient with acute promyelocytic leukemia treated with all-trans retinoic Acid. Retin Cases Brief Rep. 2013;7(1):46-49. doi:10.1097/ICB.0b013e3182618d6c
Hua HU, Rayess N, Moshfeghi AA. Acute Promyelocytic Leukemia With Sudden Vision Loss. JAMA Ophthalmol. 2020;138(2):206-207. doi:10.1001/jamaophthalmol.2019.4838
Tam EK, Ness S, Peeler CE. Exudative hemorrhagic retinopathy related to all-trans retinoic acid differentiation syndrome in a patient with acute promyelocytic leukemia. Int J Ophthalmol. 2021;14(2):323-325. doi:10.18240/ijo.2021.02.22
How to Cite
“ATYPICAL DIFFERENTIATION SYNDROME WITH SUDDEN VISION LOSS IN ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA PLUS ATO: A CLINICAL CASE” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024063. doi:10.4084/MJHID.2024.063.
Copyright (c) 2024 Eleonora Boscaro
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
